This report studies the Atrial Fibrillation Devices market. Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Atrial Fibrillation Devices are the devices used for atrial fibrillation therapy, including access, diagnostic, visualization and ablation products to assist physicians in diagnosing and treating various irregular heart rhythms.
Market Analysis and Insights: Global and United States Atrial Fibrillation Devices Market
This report focuses on global and United States Atrial Fibrillation Devices market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Atrial Fibrillation Devices market size is estimated to be worth US$ 3399.4 million in 2022 and is forecast to a readjusted size of US$ 5576.8 million by 2028 with a CAGR of 8.6% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Catheter Ablation accounting for % of the Atrial Fibrillation Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospitals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
The leading manufacturers of atrial fibrillation devices include Johnson & Johnson, Boston Scientific, Abbott, Medtronic, Japan Lifeline, and Atricure, with the top three accounting for about 65%.
North America is the largest market with about 35%, followed by Europe with about 30%.
Global Atrial Fibrillation Devices Scope and Market Size
Atrial Fibrillation Devices market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Atrial Fibrillation Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Atrial Fibrillation Devices market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Catheter Ablation
Maze Surgery
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Johnson & Johnson
Abbott
Medtronic
Japan Lifeline
Boston Scientific
Atricure
Biotroik
OSYPKA
Cardiofocus
MicroPort EP MedTech
Synaptic Medical